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Br.east Neoplasia - The etiologic role of estrogens 
-
I Introduction: 
A. Opening remarks 
Breast neoplasia has long held the interest of both laboratory 
and clinical researcher. As a.n index of the avidity of this interest 
it is worthwhile to note that in 1960 the Cumulated Index Medicine 
four hundred and ninety articles are listed under the category of 
breast neoplasia. These four hundred ninety articles deal with 
the etiologic, immunologic, and virologic studies of breast 
neoplasia, as well as its treatment, both medical and surgical. 
They were selected from the nine hundred and five publications 
that the Index Medicu.a regularly reviews; but fails to include 
-
recent books and independent foundation symposiums. This is 
all pointed out to convince the reader of the massive amount of 
information related to the subject and of the need to restrict 
interest to specific limited .t.reas. Such restriction is best 
achieved by examining the hypotheses that while the appearance 
of mammary neoplasia is influenced by the presence of the pro-
per stimulating conditions, in this particular case estrogens and 
other growth stimulating hormones, the real etiologic agents are 
those which induce a basic alteration of cellular genetic components 
resulting in cells having the ability to grow free of normal res-
trictions. Agents which ma.y act as such etiologic agents include 
viruses, chemical carcinogens and hormones themselves. By so 
limiting the topic the following broad are•• of interest will be 
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excluded: 1) effects of radiationJ·(l~) Z) effects of breeding, 
pregnancy and lactation;..( < 7 ~). 3) effects of hormones on the 
transpla.nta.bility of turrorA; (74) and 4) a. review of the details 
of experimental endocrinology for the past ten years and its 
relation to breast neoplasia.. In place of the latter it was decided 
to present a few classic papers which, by their excellence, have 
defined the understanding of a la.r1e area of interest. 
B. Current therapy: 
The vast amount. of work published yearly related to mammary 
carcinoma reflects the fact that it is the molft common single 
cause of ma.l~gnancy among women. This year some 54,000 
women will develop this disease and Z3, 000 will die of its 
effects a <40) :l'herefore, the need for firm criteria of treatment is 
important. and in general follows the original suggestions of 
Haagensen. <45 ) For the patient who does no~.: have a) extensive 
inflammatory carcinoma; b) involvement of the supraclavicular 
lymph nodes; c) axillary lymph nodes more that Z. 5 em. in 
diameter or those which are fixed to the thorax; d) extensive 
ulceration of the tumors, or fixation to the thorax; e) wide 
spread cutaneous metastases; f) edema of an arm, or of the 
breast or; g) distant metastases by x-r.ay, in lungs or bones--a 
classic radical mastectomy following a positive biopsy is the 
preferred method of treatment in the United Statea·.. Most 
people feel that this operation should be followed by irradiation 
therapy to the aodllary supraclavicular and internal mammary 
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areas. The second line of therapy used in the combate of in-
operable breast carcinoma, whether primary or recurrent 
and/ or metastatic postoperative is falliative treatment by radio-
therapy. The exception i8 that of metastatic lesions of soft tissues 
in women five years or more postmena_pausal For,au.c~ patients 
primary }¥1lliative treatment by estrogens is preferred. 
Third line therapy, again pa,lliative in nature, is hormonal 
manipulation. The first step is elimination of estrogens by 
bilateral oophorectomy of preme~·pausal females. When growth 
of the carcinoma continues or reasserts itself, testosterone 
therapy, an antagonist of estrogen, is instituted. If following 
oophorectomy and testosterone therapy the disease is still un-
controlled, moduate doses of adrenal cortical hormones are 
given in an effort to suppress the functioning of the adrenal 
cortex··-a,po:ssible source of estrogens. With continued lack of 
control and daring on the part of the surgeon the patient may 
now be treated with adrenalectomy to further reduce estrogens 
and/or hypopllysectomy in order to eliminate gona.dotrophic 
hormones and stimulation for the elaboration of estrogens. Re-
ported results suggest that followin& hypophysectomy remission 
may last up to U -15 months. (1, Zl, Z7 • 58) 
From this brief review of the treatment of cancer of the 
breast it should be clear that hormonal therapy is an extremely 
important medical problem. ,Estrogens appear to stimulate the 
growth of breast ca.ncer in premenopausal women and inhibit it 
.. 
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in women five years postmen.opa.usal. It is hoped that by examining 
the etiology of breast cancer, with special interest on hormones, 
that some understanding of the mechanism by which neoplasia is 
induced will result. Furthermore, it is hoped that such under-
sunding will lead to better treatment and possible prevention of 
the disease. 
c. Historical Data: 
Interest in the action of hormones began with Schinzinger 
in 1889, who, after observing atrophy of breast tissue following 
menppause, suggested oophorectomy of premenopausal women 
(5 34 78 84 ) 
with cancer of the breast. ' ' ' • Some years later, in 
1896, two cases of breast cancer in premenopausal women 
treated by oophorectomy with beneficial results, were reported 
by G. T. Beatson. (5) Lett reported in 1905, on 99 cases treated 
with oophorectomy. In hie series 36.4 per cent showed 
"marked to distinct" improvement. (S9) Interest waned until 
1914, when Torek reported one case in which eight months after 
oophorectomy nodes in a radical mastectomy scar completely 
disappeared. <96> This work was followed up by Loeb, who in 
1919 reported that in strains of mice with a high incidence of 
breast cancer, castration before the age of 6 months prevented 
the development of mammary cancer. <60) 
General appreciation of the importance of hormones to 
breast cancer awaited the pioneer work of Lacassagne, who 
succeeded in producing cancer of the breast in virginal female 
,, ' 
• 
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mice of high t\lmor strains by injecting large amounts of estrogenic 
hormones over long periods of time. (56 • 79> Since that time 
there has been a. great prof\lsion of papers on th~ &\lbject, and it 
is not the purpose of this thesis to review all of the experimental 
findinJ&. Only those papers which are either classics in the 
field or pertinent to the development of my argument of carcino-
genesis will be presented directly. 
ll Laboratory Data: 
The laboratory data pertinent to the paper deals with three 
broad classes of a1ents: hormones, carcinogenic hydrocarbons, 
and vir\l&es. These latter two m\lst be discussed because their 
possible roles in the induction of breast cancer has been exten-
sively st\ldied and their importance is stressed by many investi· 
gators. The discussion of mamm,otrophin and growth hormone, 
in addition to estrogens, is equally necessary because estrogens 
function in the organism only by way of complex feedbacks and 
controls involving these hormones. Since the action of many 
agents will be dealt with it collld be an easy matter to spe11d 
pages upon pages in disc\lssion of laboratory methods, results 
and conclusions. This would not be of benefit in this still highly 
speclllative field, and therefore, only those results are pre-
sented which f\lrther the development of a well-documented 
argument. 
i. 
"Number 
of Rat 
Male&t 
Female 
4.J. 
8+-
13-1 
·4 "' 
zs 6 
18 "' 
11~ 
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A. ovarian Hormone: estrogens 
In his classic work on castrated male and female rats, 
Geschichter demonstrated that by using various doses of estrogens 
at greater tha:n physiological levels there is an increased incidence 
of adenocarcinoma of the breast. (39) The estrone was applied 
either intramuscularly or as pellets under the skin or in combina-
tion. It was found that tumors developed most rapidly at doses 
or ZOO gamma daily via the intramuscular route. There follows an 
example of his data: 
Number of Days 
cancers Age at st&rt Required to 
Estrone dosage produced of treatment produce cancer 
50 ~ /day 3 males Zb days 534 .. 565 
100 'If /day 1 female and 37 dc1ys 359 .. 400 
3 males 
ZOO ~/day 5 females Zl days 150 - zoo 
zoor,day 1 female 25 days 191 
plus testosterone 
25 o I twi,:e daily 6 females day 1 150 - Z47 
plus pellets 
ZS l\ I twice daily 4 females day 1 Z08 - Z40 
plus pellets 
pellets Z females day 1 Z3- 43 
~ castrated; . / not castrated. 
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Further work by Goulds (lZ) with estrogen induced adeno-
carcinomas demonstrated that such tumors can metastasize and 
be transplanted there by exhibiting characteristics in common 
. (76) 
with spontaneous mammary adenocarcinoma. It is of 
interest that MacKenzie <64> in equa.lly well controlled experi· 
tr.ents, demonstrated an increased incidence of mammary 
cancer in rats treated with estradiol pellets. 
B. Pituitary Hormones 
1) Mammotropin ( Prolactin ) 
That other hormonal elements are of impor-
tance in the study of carcinoma of the breast became 
obvious with the observation that in mice with cancer 
of the breast there is an enlarged pituitary due to the 
proliferation of the cells which secrete manu~.:.,tr .... J.-ic 
hormone. These cells are identical to those observed 
to proliferate in estrogen treated rats and mice, (lO) 
and to regress in ovariectomized animals. In 1957, 
Bielachowsky reported that 81 per cent of virgin 
N Z Y stra.in mice and 91 per cent of bred mice with 
mammary tumors showed an enlarged pituitary 
gland. Furth, et al, (3S) proved that the prolifer-
ated cells produce . mcm.motropin and that their 
proliferation is dependent upon estrogen stimulation. 
·'· 
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~) Growth Hormone 
Moon, et a.l, <66) in 1950, using rata which had 
already reached a plateau in their growth injected pitui-
tary growth hormone intraperitoneally daily, 6 da.ys a 
week, for a maximum period of 485 days and demon-
strated that the animals had a.n increased incidence 
of breast lesions. The treatment with growth hor-
mones resulted, specifically, in the formation of 
fibromata and fibroadenomata.. These lesions were 
considered by the authors as being of a precancerous 
nature. In addition, hyperplastic changes were also 
seen in the ovaries and uterus of the experimental 
animals indicating the general somatic effect of the 
hormone. The appearance of such lesions in rats 
receiving nonphysi ologic doses of growth hormones 
was confirmed by Noble. (76) 
That non-physiologic doses of these growth stimulating 
hormones are positively correlated with the incidence of mammary 
tumors has been confirmed by many investigators and has led to 
the concept that the "physiologic" development of the n·1a.mmary 
(3, ~3, 46,47' 49, 61) 
gland is a prerequisite to the appearance of breast cancer. 
This normal development is dependent upon the action of several 
known hormones including estrogens, ma.mmotropins, and 
prolactin. This data, however, should not be mistaken a.s proof 
>. 
Page 9 
that hormones are carcinogenic. Perhaps it is the metabolic 
derivatives of the hormones that are carcinogenic; or it may 
be that the hormones are only indirectly carcinogenic by in· 
citing celh to produce substances that are carcinogenic; 
or that the hormones 'stimwate or permit latent neoplastic 
cells to grow and to reproduce. <7 • 37} 
C. Carcinogens and Polycyclic Hydz:oca.rbons 
A carcinogen is a compound the application of which 
reswts in the alteration of normal cells to anaplastic 
cells with the resultant appearance of a neoplastic growth. 
The identification of such compounds in the early studies 
of bladder and skin cancers led investigators to search 
for compounds which might similarly induce mammary 
tumors. 
1} Acetaminofluo.reae ,; 
In 1944 Bielschc.wsky reported an increased 
incidence of mammary tumors in rats receiving 
a daily dosage of 4 rr.g •. of acetaminofluorene 
for 30 weeks. (S} The following is a summ•uy 
of his data: (See chart page 10) 
~ 
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Castrated Spayed Total malignant 
Male Female Rl&le female 
Total ---
numbers: 41 36 5 11 
Malignant 
hepatoma: 34 11 5 5 
Mammary 
* cancer: 3 2.3 1 
Cancer of 
intestine: 3 
Tumo1· of 
uterus: :1 
Cancer of 
skin: 1 
Leukemias: z 1 1 
from the above data it con be seen that "--acetamino-
fluorene significantly increases the incidence of tumors 
in 1·ats, the site of which is influenced by the sex of the 
4nima.l. Thirty-four of forty-one males developed 
malignant hepatomas where as twenty-three of thirty-
six females developed carcinoma of the bre.ut and 
only one out of eleven spayed females developed c1 
comparable lesion. F'rom this and other experi-
ments (9, 29 • 9l, lOO) it has been concluded that the 
ovaries cl.re of grec~.t importance for the development 
tumors 
105 
55 
27 
5 
1 
l 
4 
of the breast lesion. The studies of Cantarow, et al(2.2 , 90> 
demonstrate that the incidence of mammary carcinoma 
in non-breeding female rats receiving 2-acetamino-
.. 
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fluorene was not increaeed by the simultcmeous 
administration of estrogen but was euormously in-
crec1.sed by progesterone. He concluded. th<.~.t amall 
amounts of estrogen are probably necessary for the 
appeard.nce of the neoplastic changes Cd.used by 
z ... a.cetaminofluorene' but that the quantity of 
progesterone, the luteic hormone of the ovary 
which stimulates acinar proliferation in the mam· 
mary gland, may be a limiting factor • 
Z) Methylcholanthrene 
The carcinogenic activity of ;;nethylcho· 
lanthrene was first recognized in 1940, by 
Dunning et al, (ZS) who, following the implanta-
tion of methylcholanthrene pellets into the breast, 
demonstrated the appearance of squamous cell 
metapl.:A.sia. and duct.:A.l epithelial hyperplasia which 
persisted into the period of t1.1mor formation. 
Shay•s group (SS) in 1949 administered methyl-
cholanthrene by way of gastric instillation to 
non-castrated female rats with resultant adeno-
carcinoma of the breast developing in 50 - 70 
per cent of the d.nimals depending upon the strd.in. 
They also found a sharp decrease in the incidence 
of such induced cancer in females castrated e<i.rly 
in life. Therefore, a possible role of methyl-
Fa.ge 12 
cholanthrene in the induction of brea.s t neoplasia 
has long been suspect. Like Z...kacetaminofluorene, 
its action appeared to positively correlate with 
associated hormon.a.l stimulation of the trophic 
(26,65) 
organ. 
3) Additional Compounds: 
Additional compounds have since been 
found to be active, including most prominently 
9:10- dimethyl- 1:2 benzanthracene (SO) and 
urethane. (Jl) The latter not being a. poly-
cyclic hydrocarbon. 
Can we now deduce that we are ded.ling with two phenomena--
on the one hand the tumor inducing action of hormones and on 
the other that of carcinogenic agents? As comforting as such 
a hope might be, the recent work of Huggins (Sl) demon-
strated that after the induction of a tumor with methylcholanthrene 
its growth could be altered by hormonal manipulations. 
The following is an example of his data: ( See chd.rt Page 13) 
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Number of Increasing Decreasing 
rats with size of size of 
Categpry tumors tumors tumors 
Intact .. no treatment 10 10 0 
Intact .J dihydro-
testosterone 1 mg. 9 7 
Intact.;. dihydro-
testerone Z mg. 8 1 7 
Ovariectomized i) 1 7 
Ovariectomized -1 diethyl-
stilbesterol 5 g. 10 10 0 
Hypophysectomized 10 0 9 
From the data it can be seen that the mammary tumors which 
had been induced by the methylcholanthrene, in intact females 
and in ovariectomized females receiving an estrogen substitllte, 
all had increased tumor growth, while the methylcholanthrene 
induced tumors in intact and ovariectomized animals receiving 
testosterone compounds had a decrease in tumor size. Lastly, 
all the animals hypophysectomized had a similar decrease in tumor 
size. 
From these few selections of the massive amount of data in 
the literature it is obvious that the etiologic role of two classes 
of agents must be accounted for: 1) growth stimulating hormones--
most importantly estrogens. mammotropin and growth hormone 
and: 2) carcinogenic agents, especially the polycyclic hydro-
carbons. In addition, the possible interaction between these two 
groups, whether summation or potentiation, must likewise be 
considered. 
• 
.· 
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D. Viruses 
The many years of work and the impressive amount of data 
relating hormones and carcinogens to the induction of neoplasia 
did not convince a. large group of researchers that the &nswer 
to the etiology of cancer had been achieved. They, like many 
since Pasteur's time nourished the hope that some infectious 
agent would be found to be the cause of Cd.ncer. Vilhelrr.. 
Ellerman and 0. Bang of Denmark ( according to Stewa.rt(S9)) 
succeeded in transferring fowl leukemia from one animal to 
another by cell free extracts and filtrates of blood. The can-
cer was accordingly attributed to a "filterable 11 virus, that is, 
an agent so small it could pass through the pore of a filter that 
held back cells and the smallest form of bacteria. Similar ex-
periments with the spindle cell sarcoma. of chickens by Roue in 
I 
1911 showed that e1 transferable ''filterable" agent could tre1nsmit 
the sarcoma.. (80) It wc1s then lean pickings for many v~ars 
until Shope in 1933 using filtered extracts of papillomas from 
wild cottontail rabbits of Minnesota induced papillomas in domestic 
rabbits. <49• SO) These induced papillomas, when growing vigor-
ously, showed graded malignant alterations often eventuating in 
.great anaplasia.. Metastases from such tumors were frequent 
and transplantation to another host successful. (83, 81, 86) 
A second filterable agent causing neoplasia in a mammal 
was isolated by Bittner in 1936. (ll) Early in his studies he noted 
• 
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t. hat the offspring of females of a high cancer inci. dence srain 
likewise developed breast cancer. When they were nursed by 
animals of a strain with a low inCidence of mammary cancer 
the development of such neoplasia. was m.-rk.edly reduced. He 
concluded that the milk of the mothers contained an agent which 
caused the cancer and it was from this milk that he was able to 
isolate a filterable agent which when given to mice of low cancer 
t . d ,, h' ., f (ll,i3,14) s ra.1ns cause a n1g 1nc1o.ence o mamtn<i.ry turrwr. 
Since that time it has been found that mammary cancer develops 
following matings between agent free females and males of 
cancerous strains because of male transmission of the 
filterable agent. The agent has also been recovered from 
the contents of the semin&l vesicles and cauda epididymus of 
males of cancerous stock. 
Most recently Gross in 1951 described tlle induction 
of leukemia in newborn mice by me.A.ns of a cell free extr.a.ct. of 
mice suffering with a spontaneous leukemia. <44) Stewc:~.rt, in 
an effort to confirm Gross • work, found malignancy of the 
parotid gland to be present in addition to the i nd~ced leukemias. 
Therefore, she concluded that a filterable agent could cause leu-
kemia and parotid cancer in mi.ce. (B9) By way of culture 
techniques employing mouse embl"yo celb, extracts high in viral 
concentrations were produced which, when injected, produced tumors 
in 85 - 100 per cent of the experimental mice. The induced tumors 
were not only of the parotid gland and leukemias, but included a 
wide variety to &d.rcoma.s and carcinomas, including mammary 
I 
I 
i 
~ I 
t 
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gland lesions. Serial passage, dilution, and culture techniques 
have proven that these are all manifestations of the same viral 
infection. The agent also affects all strains of mice, as well 
as hamsters, rabbits, and rats. Since the initial excitement 
it has been shown that the agent of Gross • leukemia is entirely 
different than that of Stewart's "Poly.orna" virus. 
It can be seen then that viral agents have been shown to 
be capable of inducing widespread sarcoma. and carcinomas, 
including carcinoma. of the breast, in a wide variety of la.bora· 
tory animals. Therefore, one must consider if viruses play 
a role in the induction of breast tumor in human femd.les c:md 
if so what their relation is to other possible etiogic agents--
hormones and polycyclic hydrocarbons. 
III Initiating and Promoting ~tents 
Attention must next be turned to the problem of how, in 
general. b.ormones, polycyclic hydrocarbons, And viruses, 
function to ~nduce the appearance of neoplae_tic growth. An 
Answer suggested by Friedewald (33) and Foulds (3Z) is 
that some Agents, specifically polycyclic hydrocarbons such 
as benzpyrene and methylcholanthrene, are capable of con-
verting previously normal cells into "latent tumor cells"· , The 
action of such so-called "initiating agents" is thought to b2 sudden 
and irreversible following even a. single application of the carcino-
gen. (o) These "latent tumor cells" generally remain hidden 
entities not ordinarily developing into neoplastic growths. If such 
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development occurs it requires agents which did not themselves 
initiate the neoplastic change but stimulate the proliferation of 
such cells, thereby resulting in the c~.ppearance of a tumor. 
Included as "promoting agents': are turpentine, irritc~.nt exudates 
and wound healing. (33) Therefore a. tumor begins with c:~.n initia· 
ting agent abruptly causing a change in normal cells resulting in 
the formation of "latent tumor cells". These cells, unique to the 
organism, become apparent only because of proliferation secondary 
to the stimulation of a promoting agent. Such growth initially de-
pends upon the continued presence of the promoting agent .:1nd with-
drawal results in tumor regression .:1nd revers.:1l of the neoplastic 
cells to the subthreshold state. This is "responsive" tumor 
behavior. 
If, in a hypothetical tumor after !'responsiveness" has 
been demonstrated, it is suddenly found that the tumor continues 
to grow in an anaplastic manner without the preaence of a pro-
moting agent, then the tumor is said to have "progressed" from a 
"responsive" to an "unresponsive" state. S11ch a change as a rule 
is abrupt and occurs unpredictably, sometimes early and some-
times late in the history of a particular tumor. When multiple 
tumors are present, progression takes place independently 
indicating that intrinsic alterations of the various cells is the 
mechanism of progression rather than the influence of the in-
ternal host environment. "Responsiveness" is only one mani-
testation of progression. Rarely, the growth rate will abruptly 
. (3Z,35,75,101) 
progress without any accompanying change 1n ''responsiveness". 
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Now we can define progression as the a.ppe11.rance of irreversible 
qualitative anaplastic characteristics in the development of c:t. tumor 
from a benign growth to a more malignant growth. It must be 
stressed that the change is always in the direction of increased ana· 
plasi.a. (Sl) The general principles of progression include: 
1) ~ndependent proaression of tumors: 
If multiple tumors are present ( even in the same 
organ) only one will progress a.t a. time. 
2) Independent progression of chara.cteristi~ 
Tumors which regressed after the withdrawal of 
the promoting agent ma.y recur as unresponsive tumors 
after having lain dormant and without the stimulus of a 
promoting agent. 
3) Progression is continuous or discontinuous 
by gra.dual change or by a.brupt steps. (3Z) 
(38) 
According to a. review by Gct.rdner carcinogenic hydro· 
carbons may be considered initiating agents, and the hormonal 
environment the promoting agent necessary for the physical mani-
festa.tion of the "responsive" nodule. The hormones of major 
importance are those thCA.t stimulate growth- -estrogens • mammo• 
(69) 
tropin And growth hormone. The rate of progression of a 
tumor depends upon further ana.plCLstic alteration of the cells and 
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relies on the action of the growth stimulating hormones. These 
latter agents function, according to Gardner, by stimulating cells 
already in the "latent tumor cell" stage to proliferc~.te and thereby 
allow further progression of the tumor. Therefore, hormones are 
thought to have nothing to do with tumor progress except that they 
increase the population of the cells upon which some other agent 
of causal factor may act or has &cted; the hormones by increasing 
the cellular populatior allows the "latent tumor cells" to mani-
fest themselves. <38• 71 • Z3 , lOZ) 
IV Regulation of Tissue Growth. 
The ability of an organism to regulate the ti.z.e of its own tissues 
has long been of interest to the physiologic and oncotic researcher• 
Aa; early as 1~95, Ribbert suggested ( according to Crile (Z4)) that 
cells normally act to restr&in the growth of adj.acent cells and that 
m&ligna.nt change was the loss of such restraints. This concept, 
vital to contemporary thought concerning malignancy, lay dormant 
until 195l, when Weiss suggested that the synthesis of cellular pro-
toplasm within a specific organ is accompanied by the production 
of "templates" for further reproduction and by the production of 
accessory diffuseable compounds capa.ble of inactivating such 
(98) 
reproduction. These diffuse.able compounds are thought to 
accumulate in the humoral pool, and when they reach a critical 
level, growth ceases. Partial removal of an organ reduces the 
" 
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amount of dif!usea.ble compounds reaching the humoral pool, and 
(Z4) 
allows for the compensatory growth of the organ. Crile 
developed the theory still further suggesting that ed.ch portion of 
' 
the bouy puts out a hormone that indicates to other cells and tissues 
that it is intact, functioning, hurt or in need of rep;a.ir. S•~ch hor-
mones he labelled "signal substance". As an example, the 
"signd.l substance" of the breast might help to control the output 
of the mammotropic hormone of the pituitary, and therefore 
regulate the growth of the breast. The !!!Upposition is that perhaps 
every tissue puts out nsigna.l substance 11 and in that way shuts off 
some kind of specific trophic substance. The theory is basicG.lly 
a hormond.l or trophic concept considering cellular growth res-
ponsible for the elabord.tion of hormond.l like substances and 
thereby regulating growth. .\ second theory develops what is 
considered to be d.n immunological concept. 
The immunological control of tissue growth, by far the 
more popular of the two theories, considers that the control 
of tissue growth is the result of t:l.n immunological interaction 
between adjacent cells. Originally Burnet and Fenner (ZO) 
suggested that cells elaborate a ''self marker'' which has the 
same chemical nature as antigens differing only in molicular con-
figuration. 1 hese "antigens" G.t the periphery of a normal tissue 
mass, come into contact not with a "complementc1ry recognition 
unit" ( i.e. identical cells) but with c1nother cell type to which 
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they are not acceptable nor which is acceptable to them.. (S4) 
This result in an "immunological interaction" such that further 
iatermingling of the two cell types does not occur. The concept 
is that during fetal development adjacent cell types become 
mutually antigenic by the interaction of "self marker antigens" 
resulting in the definition of orgAn bounderies. (18,19) 
Malignant growths are postulated to result from the in-
ability of the body to regulate tissue growth due to a modification 
or absence of "identity proteins" ( "self marker antigens") • 
If this is true, then lesser degrees of malignancy will be 
associated with a correspondingly small loss of "identity 
(41) 
proteins". According to Green, the degree of freeC!om 
of such cells depends upon the number of "identity proteins' 1 
that are lost, for several may fuction to determine the identity 
of the cells. This loss or modification in itself consitutes the 
the neoplastic change and progression is understood to represent 
an ever increasing degree of this loss. (ZS, 32) Cells that are 
free of "identity proteins" are then no longer under immuno-
logical restraint and are therefore free to invade and to seek 
adequate nutrition whenever available. 
The production of "identity protein'', like all other proteins 
manufact11red by a cell, is thought to be controlled by the cellular 
nucleic acids, both the cytoplasmic ribonucleic acid (RNA) a.nd 
the nuclear deoxyribonucleic acid (DNA). These nucleic acids 
are considered macromolecules which carry large amounts of 
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detailed information useful "for the coding of other molecular 
species" (6Z) They appear to exert their effect by controlling 
the formation of cellular enzyme systems and thereby indirectly 
regulating the production of cellular proteins. (4 Z) It is the 
cellular proteins reflecting the result of depletion, addition, or 
reor~anization of the components of the nucleic acids that are 
modified in neoplastic disease. These changes in the nucleic 
acids may occur suddenly and at random and are then referred to 
.a,8 somatic mutations. In a fully developed animal the only 
significant somatic cell mutations are those which confer a 
proliferative advantage on the descend<lnt and ip~c facto 
(17' 43) 
start them along the road to malignancy. The 
proliferative advantage is gained only if the mutation, by 
indirectly causing an alteration of cellular protein, is reflected 
·in the new immulogical balance between cells. T~erefore, such 
immunological changes should be understood to be biochemical 
manifestations of alterations in cellular nucleic acid. <4 • 87) 
Malignancy, therefore, is an unrestricted growth reflecting 
a somatic mutation which resulted in the loss or modification of 
"identity proteins" and which, by the same token, freed the 
cells of immunological restrictions. We must then consider how 
viruses, carcinogens and hormones may bring about a 
somatic mutation. 
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V. Mechanism of Action of T~mor Inducing Agents. 
A. Viruses: 
Viruses are genetic elements consisting of deoxyribo-
nucleic acids and ribonucleic acids surrounded by a shell of 
protein. The a.hell protects the nucleic acids from cellular 
nucleases and is essential for the cell to cell transfer of the 
(6Z) 
agents. Once the vi ruse a gain admission to the cell they 
take over the metabolic machinery and put it to work manu-
facturing viruses and the proteins of the viral shell. An over· 
whelming infection with a viruW viral agent results in the 
inability of cells to reproduce themselves or results in frank 
cellular necrosis. A less ~,'vc.<l•"t'infection is signified by some 
recognizable modification in the genetic charcteristics of the 
cell. Such. a. modification induced by the viruses may dis-
engage the cell from the controls that keep it functioning as 
a part of an organism and allow it to pursue a career of wild 
proliferation. (B9) In such cells the virus is no longer anti· 
genically demonstrable by a. known means, possibt y d~e to an 
inability of the virus to produce its protein shell or an inability 
to pull its various components toaether. At any rate, the virus 
is thought to be replicating with the cells but contained in a 
non-infectious formand)a thought to be present because of the 
. (62, 87) 
behavior of the cell. 
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Early in the studies of viruses only those composed of 
deoxyribonucleic acid were thought effective for the induction 
of the changes in the nuclear DNA which ultimately alters 
cellular immunological balance and allows for wild prolifera-
tion. For that reason only DNA agent~!, were thought capable 
of inducing tumors. Later the experimental work of Rous 
with tumors induced by fowl virus showed the agent to be 
ribonucleic acid and to contain no DNA. This allowed for the 
conclusion that RNA can serve as an incle~ndent genetic 
determinent and the ribonucleic acicl .can mutate <l.nd replicate 
and thereby cause changes in cellular enzyme systems and 
proteins which in turn allow for wild proliferation. (Z, SS) 
According to Luria, <6Z) infection by a virus may arise 
by three possible pathways: 1) exogenous; Z) "vertical'' 
transmission through germ cells or the genital tract and 
3) de novo origin from non-infectious proviruses or other 
(88) 
cellular constituents. Stanley points out that such a view 
may lead to slip shod thinking and contends that it is necessary 
to attempt to answer Koch's postulates in the study of human 
cancer. The attempt should include the isolation of the virus 
from diseased tissue and an inability to find it elsewhere. In 
addition, the disease should be produced in man or his tissues 
or organs in laboratory cultures upon the inoculation of the 
virulll), and the virus should subsequently be recovered, serially 
' 
Page ZS 
passed and proved to be the same as that inoculated. 
B. Carcinogens: Polycrclic Hydrocarbons 
These compounds, though long associated with malignant 
alteration, are still the center of a controversy. One school 
of thought suggests that they function by directly altering the 
immunological restrictions of the cell while the other school 
suggests that they are merely co-carcinogens stimulating the 
action of a virus. 
As chief exponent of the first view, Green in 1954 reported 
that there were two groups of polycyclic hydrocarbons which 
differ only by their effect on the growth of transplanted malignant 
tumors. One group acta as a. tumor stimulant and the other a.s a. 
tumor inhibitor. These latter compounds, an example of which 
is 3, 4 - benztetra.phene, do not inhibit somatic growth, are non-
carcinogenic and are non-toxic. They have no effect on spon-
taneous or chemically induced tumors and only retard the growth 
of transplanted malignant tumors when treatment is started 
early. Green suggests that these compounds link with a. specific 
protein to form an antigen which stimulates antibody production. 
Implicit in his experimental results is the suggestion that they 
join only with isoantigen& and therefore inhibit only transplanted 
tumors. <43) 
Important to this theory is the concept that the tumor 
• 
' 
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stimulating compounds (the carcinogens) likewise stimulate 
antibody production. Evidence indicates that these compounds 
link with a. lipoprotein to form antigens and that the resulting 
"foreign cells" during the initiated or pre -cancerous state 
may totally disappear in the antigen-antibody and inflammatory 
reactions. However, some of the "foreign cells" survive, 
partially because they were not modified enough to elicit a lethal 
immune reaction, or because inflammatory hyperplasia of both 
the normal and modified cells may more than compensate for 
the rate of destruction, or because of the promoting action of 
the specific carcinogen. Therefore, present simultaneously 
is a shift in the immunological balance between cells and a sti-
mula.nt for cellular growth. Then, by way of selection and 
adaption ( a phenomena familiar to the microbiologist) the cells 
surviving are those which have extruded or lost the a.ntigenically 
a.ctive .. though modified protein or have lost the enzyme system 
required for its syntht;sis. The cell is then free of immuno-
logical restraints and can behave in a malignant manner. <43) 
This explanation of the mechanism of action of carcinogens 
is complete only if Stewart'& data (S9) showing that viral tumor 
agents may well be present in any tissue in a latent state is 
disregarded. It seems that her work forces one to consider 
that carcinogens may function by stimulating a previously 
latent viral tumor agent. 
. f~. :\· 
..... ~,. ·~ ·- . ~ 
.. 
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Neither Peacock (77) nor Murphy (7l) separately experi-
menting with fowl tumors induced by tars, were able 'using 
accepted techniques ,to demonstrate an active agent in cell free 
filtrates. Although some researchers (S?) consider this con-
clusive proof of the independent action of carcinogens, Peacock 
himself considers only poaitve results to be of importanCe • 
Negative evidence regarding ultra-microscopic agents, he 
thinks, is open to a variety of interpretations, and the con-
elusion that there h no cigent present has merit in that it is 
only the simplest explanation. Interestingly enough Mcintosh 
. (63) . 
and Selb1e found that it was poss1ble by way of cell free 
filtrates to transmit fowl sarcoma which had been induced 
by tar infection. They suggest that previously reported 
negative results may be due to variation in viral virulence 
seen in proliferating cells. 
Finally, Duran-Reynals (30) ~tuggested th..tt if a virus is 
present ina'flost in lat~nt form, and it can be demonstrated to 
be activated by a tumor inducing carcinogen then a viral 
genesis of the tumor may be suspected. Furthermore, if 
that s&me virus is later recovered from~e neoplastic lesions 
that were induced •then the theory will have been substantiated. 
In the laboratory he applied methylcholanthrene to animals 
known to have a latent fowl pox virus. Such paintings first 
' 
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resulted in acute pox lesions which later progressed to malig-
nancy. Those lesions that appeared early were of low ma.lig-
na.ncy, while those that manifested themselves after months of 
treatment proved to have widespread metastases and were 
transplantable. The fowl pox was often recovered from the 
neoplaatic lesion. 
Contrary to the opinion that the carcinogen induces the 
tumor by activating the virus is the possibility that the induc-
tion of neoplasia and viral activation are two unrelated mech-
anisms. The presence of the virus in the lesion does not con-
clusively prove that it i& the causative agent. It rnay merely 
be a contamin.t.nt that infects t]'le lesion and changes its mor-
phological characteristics. (S9) 
C. Hormones: 
That female growth stimulating honnones are positively 
correlated with the incidence of mammary cancer, <:i.nd thd.t 
they can influence the growth of tumors induced by carcino-
gens, was carefully documented in an earlier portion of 
this paper. Adding further weight to the importance of 
hormonef' is the obaervation that in some strains of m.ice 
without the mammary tumor agent (or a recognizable form 
of the agent) the only females develop~ng mammary carcinoma 
are those which have been pregnant. :Pregnancy is an extremely 
• 
' 
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complex process, involving alterations in the organism's hor-
monal balance, and it is not unreasonable to presume that 
such changes may constitute a causative factor in the induction 
(30, 68) 
of a tumor. Therefore, the study of the influences of 
hormones on the development of mamma.ry carcinoma is of 
importance. 
There are two ways in which the apparent carcinogenic 
activity of hormones can be accounted for: 
1) They act directly on breast tissue to 
induce cancer or they a.ct indirectly causing the 
hypersecretion of pituita.ry hormones, which in 
turn induce breast cancer; in both instances the 
mechanism is one of excess stimulation by growth 
stimulating hormone; 
Z) They act as promoting agents for cells 
which have been affected by some other carcino-
genic agents. (l6 ) 
Those who are strongly prejudiced to an immunological 
concept of cancer believe that estrogens work to mask the action 
of "self markers" and that the affected cells ca.n then no longer 
be recognized by adjacent cells as being beyond their fetal 
limits. Since, due to the neutralization of such 1'self markers" 
the cells are antigenically neutral, their proliferation is 
# 
Pa.ge 30 
only limited by the amount of steroid hormone available. <16 • 53) 
The contrary view grants that ne9plaaia occurs at a greater 
rate in hormone stimulated tissue than in the resting organ, 
but maintains that there is not sufficient evidence to consider 
estrogens (or hormones in general ) to be among the c:arcino-
gens. It is known that all well-studied hormonal induced neo-
plaaia.s go through a stage of dependency. Proliferation of the 
trophic: cells begins almost immediately after the administration 
of the hormones and continues only as long as the stimulus is 
present. ·During such a condition the c:hanc:~s for somatic 
mutation, viral invasion, or the action of a chemical Cd.rcino-
gen resulting in altered deoxyribonucleic acid with result<.:~.nt 
alteration of protein and therefore neoplastic growth are 
(36, 70, 8Z) 
thought to be excellent. _ 
Evidence a.nd considered opinion categorically state 
that the development of neoplasia is dependent upon an alteration 
of cellular nucleic: acid. This alteration may be due to somatic 
mutation, mutation induced by the inflammatory response 
secondary to the action of a carcinogen, or as a result of the 
i ntroduc:tion of viral nucleic acid. All three of these mechanisms 
appear to result in the formation of latent tumor c:elb. The 
development of a neoplastic growth from these cells is thought to 
be enhanced if the tissue is stimulated by a growth stimulating 
hormone--estrogen, mammotrophin or growth hormone. <67) 
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This relegates the action of these hormones to a purely secondary 
or permissive role. 
VI The Permissive Action Of Estrogens 
The growth of an organ of tissue depends upon the ability of 
cells to draw upon a source of energy which can be applied to 
the replication of the cellular nucleic acids, whatever their 
con,tiguration may be. The energy source is usually the high 
I 
energy phosphate bonds of adenosine triphosphate (ATP) <99> 
Therefore, the availability of the ATP may be a rate limiting 
factor in nucleic acid synthesis. 
The major basic source of cellular energy is the metabolism 
of carbohydrates to carbon dioxide and water. This metabolic 
process, which employs the glycolytic pathway, the pentose 
shunt, and the citric aoid cycle, depends apon the presence of 
enzymes to catalyze various reactions. Coenzymes, such as 
triphosphopyridine nucleotide (TPN) and diphosphopyridine 
nucleotide (DPN) when associated with flavoproteins, cytv-
chromes and cytochrome oxidases, also are necessary for the 
metabolism of carbohydrates. During this process there is a 
transfer of hydrogen to oxygen by way of the so.called cytochrome 
reductase system. The reduction of oxygen res\llts in an enery 
advantage for the cells. The generated energy is stored in the 
. (99) form of h1gh energy phospaate bonds. This process m\lst 
' 
• 
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be stressed. The initial reduction of the coenzymes, and the con• 
comita.nt oxidation of the substrate, is generally the first step 
in the energy storing process of the cytochrome system. 
Therefore, coenttyme avaflability may be rate limiting. · In 
addition, some reactions are specific as to which pyridine nucleo-
tide is used, thereby c~unding the importance of their 
availability. As an example, the dehydrogenation of isocitrate 
...,.. necessary for the continuation of the citric acid cycle, is TP:N, 
dependent and if TPN is not available the reaction will not "go" 
Since estrogens are known to increase organ size by 
causing an increase in organ cell populd.tion it was hoped that 
following the application of these hormones an increased rate 
of nucleic acid synthesis could be demonstrd.ted. The first 
glimmer of hope for such a. cellular reaction to estrogens was 
reported by Mueller, (o?) who demonstrated that following 
bilateral ovariectomy in rats uterine atrophy occurs. This 
, atrophy is accompanied by a decrease in cellular content of .lJl.NA. 
The administration of lf+beta estradiol t~ such animals results 
in the rapid accumulation of RNA in the cell followed by an 
accumulation of DNA after some Z4 • 36 hours. Similar 
reactions have been reported in human endometrium, placenta, 
mammary gland and pituitary but not in liver, brain, lung, or 
kidney. All of the positively rea.<±ins 'tissues have proved to be 
the so-called ntarget organs" of estrogens. 
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Tala.la.y, after confirming Mueller's results, attempted to 
demonstrate where the estrogens act to increase the availability 
of energy for the synthesis of nucleic acids. <95 ) His studies 
indicate that when estradiol is added to the non-·particulate 
portion of cellular fractions, in the presence of isocitric 
dehydrogenase, there is increased reduction of DPN. It was 
further shown that catalytic quantities of TPN are required 
for that reaction and that the TPN functioned as the original 
hydrogen acceptor and is related to the reduction of .DPN in the 
following way: 
isocitrate i TPN z .. ketoglutar.:..te + COz. .;. TPNH .j H I 
TPNH 1 Ht .j DPNi====-=DPNH f HI f TPN 
___________________ . __ ..,. _________ ---·--------------
Z~ketoglutarate I co2 I DPNH I HI 
,\ccording t;o Villee <97> it is exactly this transhydro-
genation from TPN, the original proton ana electron .:.i.CCeptor, 
to Dl-'N, the second acceptor, that estrogens stir.clllate. The 
isocitric dehydrogenation is therefore coupled tv cl.U enzyme system 
consisting of a TPN linked isocitric dehydrogen:.~.se an<'. :.1.n estrogen 
!tinnllable ti"d.nshydrogenase. Silch horrDone stirnulable trans-
hydrogenase systems c1re thought to be likewise coupled with 
glucose 6 phosphate dehydrogenase, 6 phosphoglucon~te dehydro-
• 
genase, and pres~mably to any system tha.t ca.u generate T:.PNH. 
Having proved that the reactions involved with the metabolism 
of carbohydr<i.tes a.re dependent ~pon the avQ.il.:a.bility of T i'Nt 
it was necesscl.ry to determine how the oxidized form is generated 
from the reduced form and to consider the impurtance of this 
for the synthesis of n~cleic acids. Initial work on these problems 
revealed that in most animal cells the ratio of cytoplasmic 
TFNH : TPN is greater than the ratio of DFNH : .0PN. <92) 
This is thought to indicate that the rate of oxidation of T 1-NH 
is, in genera.l, much slower than its rate of reduction. By 
( 
considering d. cell to contain only a finite amount of TFN it Cd.n 
e.tsily be realized th.:lt the 1eplenishing of oxidized 1'f--N is neces-
Scl.ry for the continued metabolism of the cell. 3uch an oxidation 
may be C:Lccomplished in one of two manners: 
1) r PNH acts as the hydrogen donor in the 
synthesis of fatty acids, steroicis, .hydro¥ylations, 
red~ctive c.:a.rboxyla.tions and the synthesi;:; vf 
ascorbic acid; 
2) Estrogen activation of trd.nshydrogenases 
(94) 
reswts in incre~sed levels of cytoplasmic .Of NH. 
It has since been shown tha.t this cytopla.smic DPNH 
formed o~tside the mitochondria can, ~nder s~itable 
conditions, diffuse through the surface of those 
organelles and be oxidized. The resulting 
• 
reduction within the mitochondria lt~d.dS ulti-
mately by way of the cytochrome reduction sya-
tem to the formation of ATF. The fin.:i.l result 
of this capture of energy is increased i3yntnesis 
of steroids, fatty acids, proteins, purin~s, 
and nucleic acids. 
There,fore it can be seen that the estrogens, in Cdta.lytic 
arr.ounts, may mediate the transfer of hydrogen from TFN to 
DPN in the presence of so-called hydrox:y.;it.eroid dehydr.o-
gena.ses. Furthermore, since reactions in glycolysis :1nd 
the citric acid cycle are dependent upon the .J.vaila.bility of 
oxidized TPN, and since the synthesis of high energy phos-
phate bonds are dependent upon the .avail<~.bility of DPNH, 
estrogen levels in sensitive cells by regulating the 
regeneration of TPN- a:nd the .. generation of 0.PNH control 
- (S2 94) 
the metabolism of the cell. ' 
Implicit in this hypothesis is the suggestion t.n.::~.t the 
growth of cells in target orgd.ns is limited by steroid mediated 
trc:mshydro~a.tions. This true of normal cells .::~.nd of hor-
_ monal dependent tumor cells. It is thought that in s·~ch tumors 
a certain proportion of cells might possess steroid independent 
enzyme systems which bypass the rate limiting function of the 
hydroxysteroid transhydrosen.ases and which, by the process of 
selection, survive preferentially and result in a hormone 
independent tumor. (93) The formation of such enzymes results 
from an altered nucleic acid template. Such an alteration 
may occur as the result of a spontaneous mutation, the direct 
action of a carcinogen, the stimulation of a latent virus by a 
carcinogen or the action of a virus itself. 
VII Summary: 
That female growth stimulating hormones·-estrogens, 
mammotropin and growth hormone, along with polycyclic 
hydrocarbons and virus agents are associated with an increased 
incidence of mammary neoplasia is documented. Tumor develop-
ment it is argued is due to the action of two types of agents: 
initiating agents (such as carcinogens) which abruptly convert 
normal cells into "latent tumor cells", and promoting agents 
which stimulate the growth of the "latent tumor cells" and 
are responsible for the progression of the tumor. Neoplasia, 
it is suggested, is the lack of restraints to cellular growth 
due to an absence of "identity proteins". The absence of 
these proteins reflects an alteration in the cellular nucleic 
acids, the macromolecules which regulate the production of 
other molecules by a cell. Agents capable of inducing neoplasia, 
(latent tumor cells) therefore, must be d.ble to modify the 
nucleic acids. Such a change may be induced by viruses which 
are nucleic acids themselves, or by carcinogens acting directly 
to alter immunologic cellular balance or by stimulating latent 
' 
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viral particles. Finally the interrelation of these agents with 
estrogen is considered and the hypothesis expounded is that 
the estrogens, by functioning as a coenzyme, stimulate the 
growth of the "latent neoplastic cells" in sensitive target 
organs. 
' 
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